ALY688-SR in Generally Healthy Overweight or Obese Adults

NCT04855565 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to recruit due to COVID-19 pandemic restrictions

Conditions

Overweight and Obesity

Interventions

DRUG: ALY688-SR

Sponsor

Allysta Pharmaceutical

Collaborators

[object Object]